跳至主要内容
临床试验/NCT01719211
NCT01719211招募中不适用

Genetic Basis of Mitral Valve Prolapse

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 1999年1月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,500
试验地点
1
主要终点
Discovery of the genetic basis of Mitral Valve Prolapse

研究概览

简要总结

The investigators have successfully identified two novel genetic loci for MVP on chromosomes 11 and 13 and are searching for altered genes in these regions. This requires recruiting large families who may have MVP linked to these or other chromosomes; and obtaining DNA samples from 1,000-1,500 individually affected patients to study the relation between DNA markers throughout the genome and MVP. It is our expectation that the results of this study will lead to the discovery of gene(s) responsible for MVP. This will lead to improved understanding of the disease and, in turn, improved ability to treat and prevent progression in genetically susceptible individuals.

详细描述

This is a genome-wide association study.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Mitral valve prolapse

排除标准

  • Other mitral valve diseases

结局指标

主要结局

Discovery of the genetic basis of Mitral Valve Prolapse

时间窗: 5 years

Genome-wide association

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert A. Levine, MD

Cardiologist

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验

Genetic Basis of Mitral Valve Prolapse | 临床试验